Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mamea Imaging was a Swedish medical technology company that pioneered the development of photon-counting X-ray detectors for digital mammography. Founded as a spin-off from the Royal Institute of Technology (KTH) in Stockholm, the company focused on creating imaging systems that provide high-resolution diagnostic images while minimizing radiation exposure to patients. Its core technology was commercialized through the Sectra MicroDose Mammography system following Mamea's acquisition by Sectra in 2004. In 2011, Sectra sold its mammography business to Philips, which continues to utilize Mamea's foundational photon-counting technology in its clinical breast screening portfolio. The company's innovations represent a significant advancement in the field of medical imaging and oncology diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mamea Imaging.